© 2022 MJH Life Sciences and Ophthalmology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Unity Biotechnology announces positive data in phase 2 BEHOLD study of UBX1325 in patients with DME
New York ophthalmologists provide eye care in Haiti
FDA approves Coherus’ interchangeable biosimilar for Lucentis